A Comparison of Five SARS-CoV-2 Molecular Assays With Clinical Correlations
- PMID: 33015712
- PMCID: PMC7665304
- DOI: 10.1093/ajcp/aqaa181
A Comparison of Five SARS-CoV-2 Molecular Assays With Clinical Correlations
Abstract
Objectives: Comparative assessments of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) molecular assays that have been operationalized through the US Food and Drug Administration's Emergency Use Authorization process are warranted to assess real-world performance. Characteristics such as sensitivity, specificity, and false-negative rate are important to inform clinical use.
Methods: We compared five SARS-CoV-2 assays using nasopharyngeal and nasal swab specimens submitted in transport media; we enriched this cohort for positive specimens, since we were particularly interested in the sensitivity and false-negative rate. Performance of each test was compared with a composite standard.
Results: The sensitivities and false-negative rates of the 239 specimens that met inclusion criteria were, respectively, as follows: Centers for Disease Control and Prevention 2019 nCoV Real-Time RT-PCR Diagnostic Panel, 100% and 0%; TIB MOLBIOL/Roche z 480 Assay, 96.5% and 3.5%; Xpert Xpress SARS-CoV-2 (Cepheid), 97.6% and 2.4%; Simplexa COVID-19 Direct Kit (DiaSorin), 88.1% and 11.9%; and ID Now COVID-19 (Abbott), 83.3% and 16.7%.
Conclusions: The assays that included a nucleic acid extraction followed by reverse transcription polymerase chain reaction were more sensitive than assays that lacked a full extraction. Most false negatives were seen in patients with low viral loads, as extrapolated from crossing threshold values.
Keywords: COVID-19; Coronavirus; Nucleic acid amplification tests; SARS-CoV-2.
© American Society for Clinical Pathology, 2020. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.
Figures

Similar articles
-
Performance of Abbott ID Now COVID-19 Rapid Nucleic Acid Amplification Test Using Nasopharyngeal Swabs Transported in Viral Transport Media and Dry Nasal Swabs in a New York City Academic Institution.J Clin Microbiol. 2020 Jul 23;58(8):e01136-20. doi: 10.1128/JCM.01136-20. Print 2020 Jul 23. J Clin Microbiol. 2020. PMID: 32471894 Free PMC article.
-
Comparative study of four SARS-CoV-2 Nucleic Acid Amplification Test (NAAT) platforms demonstrates that ID NOW performance is impaired substantially by patient and specimen type.Diagn Microbiol Infect Dis. 2021 Jan;99(1):115200. doi: 10.1016/j.diagmicrobio.2020.115200. Epub 2020 Sep 3. Diagn Microbiol Infect Dis. 2021. PMID: 32980807 Free PMC article.
-
Sample-to-Answer and Routine Real-Time RT-PCR: A Comparison of Different Platforms for SARS-CoV-2 Detection.J Mol Diagn. 2021 Jun;23(6):665-670. doi: 10.1016/j.jmoldx.2021.02.010. Epub 2021 Mar 8. J Mol Diagn. 2021. PMID: 33706011 Free PMC article.
-
Diagnostic accuracy of the Cepheid Xpert Xpress and the Abbott ID NOW assay for rapid detection of SARS-CoV-2: A systematic review and meta-analysis.J Med Virol. 2021 Jul;93(7):4523-4531. doi: 10.1002/jmv.26994. Epub 2021 May 3. J Med Virol. 2021. PMID: 33913533 Free PMC article.
-
Negative results in nucleic acid test of COVID-19 patients: assessment from the perspective of clinical laboratories.Ann Palliat Med. 2020 Nov;9(6):4246-4251. doi: 10.21037/apm-20-568. Epub 2020 Sep 14. Ann Palliat Med. 2020. PMID: 32954746 Review.
Cited by
-
The diagnostic accuracy of seven commercial molecular in vitro SARS-CoV-2 detection tests: a rapid meta-analysis.Expert Rev Mol Diagn. 2021 Jul;21(7):733-740. doi: 10.1080/14737159.2021.1933449. Epub 2021 Jun 1. Expert Rev Mol Diagn. 2021. PMID: 34015984 Free PMC article.
-
Laboratory Diagnosis of SARS-CoV-2 Pneumonia.Diagnostics (Basel). 2021 Jul 15;11(7):1270. doi: 10.3390/diagnostics11071270. Diagnostics (Basel). 2021. PMID: 34359353 Free PMC article. Review.
-
The Infectious Diseases Society of America Guidelines on the Diagnosis of COVID-19: Molecular Diagnostic Testing (December 2023).Clin Infect Dis. 2024 Jun 27;78(7):e385-e415. doi: 10.1093/cid/ciad646. Clin Infect Dis. 2024. PMID: 38112284 Free PMC article.
-
Exploring the relationship between cycle threshold values and oral manifestations in COVID-19: a comprehensive overview.Acta Odontol Scand. 2024 Sep 23;83:516-521. doi: 10.2340/aos.v83.41390. Acta Odontol Scand. 2024. PMID: 39311869 Free PMC article.
-
The Impact of the Coronavirus Disease - 19 Pandemic on the Clinical Characteristics and Treatment of Adult Patients with Acute Appendicitis.Front Surg. 2022 Mar 31;9:878534. doi: 10.3389/fsurg.2022.878534. eCollection 2022. Front Surg. 2022. PMID: 35433818 Free PMC article.
References
-
- US Food and Drug Administration. Emergency Use Authorization 2020. https://www.fda.gov/medical-devices/coronavirus-disease-2019-covid-19-em.... Accessed June 19, 2020.
-
- R Core Team. R: A Language and Environment for Statistical Computing. Vienna, Austria: R Foundation for Statistical Computing; 2020. https://www.rproject.org/.
-
- Kowarik A, Templ M. Imputation with the R Package VIM. J Stat Softw. 2016;74:1-16.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous